CD4 and neoplasm: Direct tumor recognition in all cases was antigen-specific and HLA-DR-restricted since tumor cell lines not expressing the appropriate antigen (STEAP, EZH2), and the corresponding HLA-DR molecule failed to stimulate the CD4 T-cell responses.